Michael C Lorenz (Michael Lorenz)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

mBio

Infection and immunity

PLoS pathogens

Proceedings of the National Academy of Sciences of the United States of America

University of Texas Health Science Center

Duke University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center Jun 01 2003

United States

Professor :: Microbiology and Molecular Genetics

Whitehead Institute for Biomedical Research Sep 01 1998 - Jun 01 2003

United States

Post-doctoral Fellow

Education History

Duke University Sep 01 1992 - Dec 15 1997

United States

PHD :: Genetics

Publications

Shantanu Guha, Shane A Cristy, Giuseppe Buda De Cesare, Melissa R Cruz, Michael C Lorenz, Danielle A Garsin
Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. mBio 15 (5) (2024)
Shantanu Guha, Shane A Cristy, Giuseppe Buda De Cesare, Melissa R Cruz, Michael C Lorenz, Danielle A Garsin
Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. mBio 15 (5) (2024)
Michael C Lorenz
Regulatory complexity of cellular differentiation in Candida albicans revealed through systematic screening of protein kinase mutants. mBio 15 (8) (2024)
Michael C Lorenz
Regulatory complexity of cellular differentiation in Candida albicans revealed through systematic screening of protein kinase mutants. mBio 15 (8) (2024)
Michael C Lorenz
Regulatory complexity of cellular differentiation in Candida albicans revealed through systematic screening of protein kinase mutants. mBio 15 (8) (2024)
Michael C Lorenz
Regulatory complexity of cellular differentiation in Candida albicans revealed through systematic screening of protein kinase mutants. mBio (2024)
Shantanu Guha, Shane A Cristy, Giuseppe Buda De Cesare, Melissa R Cruz, Michael C Lorenz, Danielle A Garsin
Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. mBio 15 (5) (2024)
Shantanu Guha, Shane A Cristy, Giuseppe Buda De Cesare, Melissa R Cruz, Michael C Lorenz, Danielle A Garsin
Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. mBio (2024)
Hannah B Wilson, Michael C Lorenz
Candida albicans Hyphal Morphogenesis within Macrophages Does Not Require Carbon Dioxide or pH-Sensing Pathways. Infection and immunity (2023)
Pedro Miramón, Andrew W Pountain, Michael C Lorenz
Candida auris -macrophage cellular interactions and transcriptional response. Infection and immunity (2023)
Melissa R Cruz, Shane Cristy, Shantanu Guha, Giuseppe Buda De Cesare, Elena Evdokimova, Hiram Sanchez, Dominika Borek, Pedro Miramón, Junko Yano, Paul L Fidel, Alexei Savchenko, David R Andes, Peter J Stogios, Michael C Lorenz, Danielle A Garsin
Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections. Nature communications 13 (1) (2022)
Enrico Garbe, Pedro Miramón, Franziska Gerwien, Nico Ueberschaar, Louisa Hansske-Braun, Philipp Brandt, Bettina Böttcher, Michael C Lorenz, Slavena Vylkova
GNP2 Encodes a High-Specificity Proline Permease in Candida albicans. mBio (2022)
Andrew W Pountain, John R Collette, William M Farrell, Michael C Lorenz
Interactions of Both Pathogenic and Nonpathogenic CUG Clade Candida Species with Macrophages Share a Conserved Transcriptional Landscape. mBio 12 (6) (2021)
Pedro Miramón, Andrew W Pountain, Ambro van Hoof, Michael C Lorenz
The Paralogous Transcription Factors Stp1 and Stp2 of Candida albicans Have Distinct Functions in Nutrient Acquisition and Host Interaction. Infection and immunity 88 (5) (2020)
Rosana Alves, Maria Sousa-Silva, Daniel Vieira, Pedro Soares, Yasmin Chebaro, Michael C Lorenz, Margarida Casal, Soares-Silva Isabel, Sandra Paiva
Carboxylic Acid Transporters in Candida Pathogenesis. mBio 11 (3) (2020)
Robert B Williams, Michael C Lorenz
Multiple Alternative Carbon Pathways Combine To Promote Candida albicans Stress Resistance, Immune Interactions, and Virulence. mBio 11 (1) (2020)
Giuseppe Buda De Cesare, Shane A Cristy, Danielle A Garsin, Michael C Lorenz
Antimicrobial Peptides: a New Frontier in Antifungal Therapy. mBio 11 (6) (2020)
Armand O Brown, Carrie E Graham, Melissa R Cruz, Kavindra V Singh, Barbara E Murray, Michael C Lorenz, Danielle A Garsin
Antifungal Activity of the Enterococcus faecalis Peptide EntV Requires Protease Cleavage and Disulfide Bond Formation. mBio 10 (4) (2019)
Pedro Miramón, Michael C Lorenz
A feast for Candida: Metabolic plasticity confers an edge for virulence. PLoS pathogens 13 (2) (2017)
Elisa M Vesely, Robert B Williams, James B Konopka, Michael C Lorenz
N-Acetylglucosamine Metabolism Promotes Survival of Candida albicans in the Phagosome. mSphere 2 (5) (2017)
Carrie E Graham, Melissa R Cruz, Danielle A Garsin, Michael C Lorenz
Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proceedings of the National Academy of Sciences of the United States of America 114 (17) (2017)

Michael C Lorenz.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Lorenz)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael C Lorenz (Michael Lorenz)